Carlos S. P.
- Country
- Portugal
- Department
- Intensive Care Medicine
Research Overview
Data & Insights
Has run more than one trial at 0 of 7 partner sites.
Specializations
Oncology
Investigation of malignant tumors primarily of the thorax and breast.
- Non‑Small Cell Lung Cancer
- Advanced HER2‑negative Breast Cancer
- KRAS‑mutated NSCLC
- Hormone‑Receptor Positive Breast Cancer
Emphasis is placed on molecular subtyping, disease progression, and therapeutic resistance.
Cardiovascular & Renal Medicine
Focus on vascular pathology and kidney disorders with high morbidity.
- Atherosclerotic Cardiovascular Disease
- End‑Stage Kidney Disease
- Focal Segmental Glomerulosclerosis
- Hypertension
Research targets cardiovascular risk mitigation, renal function preservation, and proteinuria reduction.
Pulmonary & Respiratory Medicine
Study of progressive lung diseases and critical care respiratory infections.
- Idiopathic Pulmonary Fibrosis
- Progressive Pulmonary Fibrosis
- Ventilator‑Associated Pneumonia
Efforts aim at slowing fibrotic decline, improving lung capacity, and optimizing infection management.
Neurological Disorders
Investigation of acute and degenerative conditions of the central nervous system.
- Acute Ischemic Stroke
- Multiple System Atrophy
- Primary Progressive Multiple Sclerosis
Clinical work emphasizes neuroprotection, functional recovery, and disease‑modifying strategies.
Gastroenterology & Immunology
Focus on inflammatory and immune‑mediated disorders of the gastrointestinal tract and related systems.
- Crohn's Disease
- Ulcerative Colitis
- Eosinophilic Esophagitis
- Chronic Rhinosinusitis with Nasal Polyps
- Alpha‑1 Antitrypsin Deficiency
Research seeks to modulate immune pathways, achieve mucosal healing, and manage systemic manifestations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.